Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This **combination** is used as an oral preoperative regimen to prepare the bowel before elective colorectal surgery. It combines **neomycin** (an aminoglycoside antibiotic targeting aerobic bacteria), **metronidazole** (an antibiotic primarily effective against anaerobic bacteria), and **polyethylene glycol** (a non-absorbable osmotic laxative that induces mechanical bowel evacuation). The antibiotics reduce colonic bacterial load, minimizing perioperative infection risk, while polyethylene glycol flushes the colon, enhancing the effect. This regimen is adopted widely in surgical protocols and is supported by clinical studies showing a significant reduction in surgical site infections and post-operative complications when used together for preoperative bowel preparation[1][2][3][5][7][8][9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on neomycin + metronidazole + polyethylene glycol.